Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ropes & Gray grows FDA practice

Executive Summary

Bennett, Turner & Coleman D.C. law firm will merge into Ropes & Gray's Health and Life Sciences Practices. Ropes & Gray, which employs two attorneys in its FDA practice, will gain BT&C's 11 attorneys with expertise in FDA regulatory issues. During a House Commerce/Oversight Subcommittee hearing on ImClone's Erbitux, a Bristol exec testified that Bennett, Turner & Coleman partner Alan Bennett informed him that a refuse-to-file letter from FDA was imminent (1"The Pink Sheet" June 17, p. 5)...

You may also be interested in...

Erbitux Hearing Puts Focus On Pre-Approval Promotion, FDA Communication

The House Energy & Commerce Committee is interested in looking further into FDA's authority to "rein in" pre-approval promotions

Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.

Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test

Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials. 




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts